Cargando…
Neuropeptide Y1 Receptor Regulates Glucocorticoid-Induced Inhibition of Osteoblast Differentiation in Murine MC3T3-E1 Cells via ERK Signaling
High dose glucocorticoid (GC) administration impairs the viability and function of osteoblasts, thus causing osteoporosis and osteonecrosis. Neuropeptide Y1 receptor (Y1 receptor) is expressed in bone tissues and cells, and regulates bone remodeling. However, the role of Y1 receptor in glucocorticoi...
Autores principales: | Yu, Wei, Zhu, Chao, Xu, Wenning, Jiang, Leisheng, Jiang, Shengdan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187950/ https://www.ncbi.nlm.nih.gov/pubmed/28009825 http://dx.doi.org/10.3390/ijms17122150 |
Ejemplares similares
-
Liraglutide Promotes Osteoblastic Differentiation in MC3T3-E1 Cells by ERK5 Pathway
por: Sun, Yue, et al.
Publicado: (2020) -
Geniposide Alleviates Glucocorticoid-Induced Inhibition of Osteogenic Differentiation in MC3T3-E1 Cells by ERK Pathway
por: Xie, Baocheng, et al.
Publicado: (2019) -
Promoting Effect of Pinostrobin on the Proliferation, Differentiation, and Mineralization of Murine Pre-osteoblastic MC3T3-E1 Cells
por: Gu, Chengbo, et al.
Publicado: (2017) -
IL‐10 induces MC3T3‐E1 cells differentiation towards osteoblastic fate in murine model
por: Xiong, Yuan, et al.
Publicado: (2019) -
Effects of 6-Hydroxyflavone on Osteoblast Differentiation in MC3T3-E1 Cells
por: Lai, Chien-Hung, et al.
Publicado: (2014)